Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.58B |
| 2 |
iShares MBS ETF
MBB
|
+$1.49B |
| 3 |
RTX Corp
RTX
|
+$839M |
| 4 |
Microsoft
MSFT
|
+$566M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$555M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$1.27B |
| 2 |
Advanced Micro Devices
AMD
|
+$920M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$682M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$567M |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$291M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 11.61% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cummins
CMI
$89.4B
| $787M | 0.34% |
2,840,172
+137,048
| +5% | +$39.2M |
|
77
AstraZeneca
AZN
$240B
| $776M | 0.34% |
4,977,993
+151,287
| +3% | +$22.8M |
|
78
Applied Materials
AMAT
$407B
| $765M | 0.33% |
3,242,049
-6,363
| -0.2% | -$1.37M |
|
79
Edwards Lifesciences
EW
$50.8B
| $764M | 0.33% |
8,271,606
+644,728
| +8% | +$57.1M |
|
80
Illinois Tool Works
ITW
$82.4B
| $761M | 0.33% |
3,212,303
+139,570
| +5% | +$34.5M |
|
81
Nike
NKE
$62.5B
| $733M | 0.32% |
9,719,975
-430,330
| -4% | -$40M |
|
82
Las Vegas Sands
LVS
$30.3B
| $723M | 0.31% |
16,339,497
+4,515,913
| +38% | +$211M |
|
83
Deere & Co
DE
$165B
| $686M | 0.3% |
1,835,925
+175,296
| +11% | +$68.4M |
|
84
GSK
GSK
$103B
| $682M | 0.3% |
17,706,481
+2,038,221
| +13% | +$85.7M |
|
85
Trane Technologies
TT
$101B
| $674M | 0.29% |
2,049,840
-16,066
| -0.8% | -$5.11M |
|
86
iShares MSCI Europe Financials ETF
EUFN
$4.25B
| $667M | 0.29% |
29,810,721
-34,462
| -0.1% | -$791K |
|
87
Sanofi
SNY
$103B
| $660M | 0.29% |
13,598,502
-349,081
| -3% | -$16.8M |
|
88
Banco Santander
SAN
$205B
| $655M | 0.29% |
141,574,002
-190,506
| -0.1% | -$938K |
|
89
Sony
SONY
$133B
| $651M | 0.28% |
38,321,400
+4,239,070
| +12% | +$70.1M |
|
90
Ingersoll Rand
IR
$33.8B
| $602M | 0.26% |
6,630,112
+121,681
| +2% | +$11.2M |
|
91
AB InBev
BUD
$167B
| $565M | 0.25% |
9,719,685
+426,299
| +5% | +$26.1M |
|
92
PACCAR
PCAR
$69.9B
| $524M | 0.23% |
5,091,680
+75,891
| +2% | +$8.37M |
|
93
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $518M | 0.23% |
51,681,220
-1,012,337
| -2% | -$10.9M |
|
94
iShares National Muni Bond ETF
MUB
$45.2B
| $504M | 0.22% |
4,732,217
+348,335
| +8% | +$37.1M |
|
95
Alphabet (Google) Class C
GOOG
$4.58T
| $486M | 0.21% |
2,647,868
-44,847
| -2% | -$7.63M |
|
96
Crown Castle
CCI
$34.3B
| $477M | 0.21% |
4,884,575
+215,516
| +5% | +$21.2M |
|
97
iShares Global Healthcare ETF
IXJ
$4.07B
| $450M | 0.2% |
4,845,011
-467,932
| -9% | -$42.7M |
|
98
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.5B
| $439M | 0.19% |
7,531,241
+606,778
| +9% | +$35.1M |
|
99
iShares Global Tech ETF
IXN
$8.38B
| $423M | 0.18% |
5,103,995
-1,047,277
| -17% | -$79.8M |
|
100
Medtronic
MDT
$110B
| $416M | 0.18% |
5,284,329
+355,906
| +7% | +$29.2M |
|
Similar funds
Ken Fisher's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Fisher held 1,069 positions worth $230B, up 7.4% from $214B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Fisher deployed $7.03B of net new capital in Q2 2024, opening 105 new positions and adding to 492 existing holdings. Its largest new stake was ZTO Express: 3,166,868 shares worth $65.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $1.27B trimmed.
- Ken Fisher's largest Q2 2024 buy was ZTO Express: 3,166,868 shares worth $65.7M.
- Ken Fisher added most to Canadian Natural Resources in Q2 2024, an estimated $1.58B increase.
- Ken Fisher's biggest Q2 2024 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $1.27B.
- Ken Fisher fully exited Thor Industries in Q2 2024, selling an estimated $24.5M.
- Ken Fisher's ten largest holdings make up 34% of its $230B portfolio in Q2 2024.
- Ken Fisher opened 105 new positions and closed 83 in Q2 2024.
- Ken Fisher's portfolio value rose 7.4% quarter-over-quarter to $230B.
Based on Fisher Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.